105 related articles for article (PubMed ID: 1326470)
21. The relevance of oncogenes as prognostic markers in cervical cancer.
Soh LT; Heng D; Lee IW; Ho TH; Hui KM
Int J Gynecol Cancer; 2002; 12(5):465-74. PubMed ID: 12366664
[TBL] [Abstract][Full Text] [Related]
22. [Gene diagnosis of uterine cervical cancer].
Nagai N
Rinsho Byori; 1994 Apr; 42(4):372-9. PubMed ID: 7909855
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between human papillomavirus and oncogenes (c-myc, N-myc) amplification in human cervical cancers].
Kinoshita M; Ikei N; Shin S; Inui S; Hirao T; Aono T
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2828-35. PubMed ID: 1963632
[TBL] [Abstract][Full Text] [Related]
24. [Carcinogenic mechanisms of multiple genes in cervical carcinoma].
Huang G; Xiao X; Huang Y; Huang R
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):5-9. PubMed ID: 9208611
[TBL] [Abstract][Full Text] [Related]
25. MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression.
Cromme FV; Snijders PJ; van den Brule AJ; Kenemans P; Meijer CJ; Walboomers JM
Oncogene; 1993 Nov; 8(11):2969-75. PubMed ID: 8414499
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women.
Das BC; Gopalkrishna V; Das DK; Sharma JK; Singh V; Luthra UK
Cancer; 1993 Jul; 72(1):147-53. PubMed ID: 8389665
[TBL] [Abstract][Full Text] [Related]
27. [Demonstration and biological significance of viral and cellular oncogenes in uterine carcinomas].
Milde-Langosch K; Wilckens C; Brack T; Löning T
Verh Dtsch Ges Pathol; 1991; 75():363-5. PubMed ID: 1724842
[TBL] [Abstract][Full Text] [Related]
28. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
29. Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papilloma virus types in preinvasive cervical lesions.
Mourón SA; Abba MC; Güerci A; Gómez MA; Dulout FN; Golijow CD
Mutat Res; 2000 Aug; 469(1):127-34. PubMed ID: 10946249
[TBL] [Abstract][Full Text] [Related]
30. Analysis and clinical implications of K-ras gene mutations and infection with human papillomavirus types 16 and 18 in primary adenocarcinoma of the uterine cervix.
Tenti P; Romagnoli S; Silini E; Pellegata NS; Zappatore R; Spinillo A; Zara C; Ranzani GN; Carnevali L
Int J Cancer; 1995 Feb; 64(1):9-13. PubMed ID: 7665253
[TBL] [Abstract][Full Text] [Related]
31. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
[TBL] [Abstract][Full Text] [Related]
33. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping.
Jones MW; Kounelis S; Papadaki H; Bakker A; Swalsky PA; Woods J; Finkelstein SD
Int J Gynecol Pathol; 2000 Apr; 19(2):110-7. PubMed ID: 10782406
[TBL] [Abstract][Full Text] [Related]
34. [Virological studies on generation of cervical carcinomas].
Yoshikawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):834-43. PubMed ID: 2172420
[TBL] [Abstract][Full Text] [Related]
35. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.
Nürnberg W; Artuc M; Vorbrueggen G; Kalkbrenner F; Moelling K; Czarnetzki BM; Schadendorf D
Br J Cancer; 1995 May; 71(5):1018-24. PubMed ID: 7734293
[TBL] [Abstract][Full Text] [Related]
36. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus, human cytomegalovirus and oncogene C-myc in cervical carcinoma and cervicitis.
Huang SL; Liu ZQ; Zhang XN; Li MJ
Chin Med J (Engl); 1993 Mar; 106(3):208-10. PubMed ID: 8391967
[TBL] [Abstract][Full Text] [Related]
38. Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus.
Crook T; Wrede D; Tidy J; Scholefield J; Crawford L; Vousden KH
Oncogene; 1991 Jul; 6(7):1251-7. PubMed ID: 1650445
[TBL] [Abstract][Full Text] [Related]
39. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
Ferguson AW; Svoboda-Newman SM; Frank TS
Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus and c-myc/c-erbB2 in uterine and vulvar lesions.
Milde-Langosch K; Becker G; Löning T
Virchows Arch A Pathol Anat Histopathol; 1991; 419(6):479-85. PubMed ID: 1661047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
